EDINBURGH - Aberdeen Group plc, an investment company based in Edinburgh, United Kingdom (TADAWUL:4280), has crossed the threshold of voting rights in CVS Group PLC (LON:CVSG), a UK-based veterinary services provider. On March 12, 2025, Aberdeen Group acquired additional shares, resulting in a total of 6.876440% voting rights in the company.
The transaction, which was notified to CVS Group on March 13, 2025, increased Aberdeen Group’s holding from the previous notification level of 5.842293%. The total number of voting rights now held by Aberdeen Group in CVS Group is 4,933,171.
This change in shareholding has been managed by the discretionary investment management entity within Aberdeen Group, specifically by abrdn Investment Management Limited. The shares are managed on behalf of clients who have delegated the exercise of voting power to the investment manager.
The disclosure indicates that the indirect holding company abrdn Investments (Holdings) Limited and the investment management entity abrdn Investment Management Limited had previously held a combined voting rights percentage that was above the 5% threshold. However, due to trading activities on March 12, 2025, their combined voting rights decreased below this threshold.
The completion of this notification process took place in Edinburgh, United Kingdom, on March 13, 2025. This information is based on a press release statement and has been provided by RNS, the news service of the London Stock Exchange (LON:LSEG), which is authorized by the Financial Conduct Authority in the UK. Terms and conditions related to the use and distribution of this information may apply.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.